Home › Stocks › TAK › All Fund Holders
TAK — TAKEDA PHARMACEUTIC-SP ADR · All Fund Holders
Funds holding (latest): 38 · Reported value held: $1.13B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Capital Research Global Investors history | Q2 2026 | 19.30M | $309.34M | 0.04% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 9.60M | $153.88M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 6.99M | $112.13M | 0.01% | Add |
| ARK Invest history | Q4 2021 | 7.86M | $107.16M | 0.34% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 5.13M | $82.15M | 0.02% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 3.73M | $59.84M | 0.03% | Add |
| BlackRock Inc history | Q2 2026 | 3.69M | $59.12M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 2.57M | $41.17M | 0.06% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 2.05M | $32.85M | 0.02% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.74M | $27.90M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 1.53M | $24.46M | 0.01% | Add |
| Wells Fargo & Co history | Q2 2026 | 1.15M | $18.45M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 1.05M | $16.84M | 0.01% | New |
| UBS Group AG history | Q2 2026 | 911.32K | $14.61M | 0.01% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 744.92K | $11.90M | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 619.02K | $9.92M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 511.34K | $8.20M | 0.01% | Add |
| Two Sigma Investments history | Q2 2026 | 485.73K | $7.79M | 0.01% | Add |
| Causeway Capital Management history | Q4 2024 | 522.03K | $6.91M | 0.16% | Reduce |
| Citigroup Inc history | Q2 2026 | 396.46K | $6.36M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 307.31K | $4.93M | 0.00% | Reduce |
| Janus Henderson Group history | Q4 2024 | 233.95K | $3.10M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 168.13K | $2.70M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 136.77K | $2.19M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 101.87K | $1.59M | 0.00% | Hold |
| Point72 Asset Management history | Q2 2026 | 77.66K | $1.24M | 0.01% | New |
| PNC Financial Services history | Q2 2026 | 49.80K | $798.25K | 0.00% | Reduce |
| Geode Capital Management history | Q4 2021 | 53.74K | $732.00K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 43.46K | $696.51K | 0.00% | Hold |
| Franklin Resources history | Q2 2026 | 40.28K | $645.72K | 0.00% | Add |
| Pzena Investment Management history | Q2 2026 | 37.82K | $606.25K | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 18.00K | $288.54K | 0.00% | New |
| Invesco Ltd history | Q2 2026 | 15.00K | $240.45K | 0.00% | Reduce |
| Prudential Financial history | Q3 2024 | 10.65K | $151.49K | 0.00% | Add |
| BROWN BROTHERS HARRIMAN & CO history | Q2 2026 | 9.33K | $149.61K | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 120 | $1.92K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 94.85K | $1.52K | 0.00% | Reduce |
| CPP Investments history | Q4 2021 | 10 | $0 | — | Hold |